Stay updated on Ociperlimab and Tislelizumab vs Pembrolizumab in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Ociperlimab and Tislelizumab vs Pembrolizumab in Lung Cancer Clinical Trial page.

Latest updates to the Ociperlimab and Tislelizumab vs Pembrolizumab in Lung Cancer Clinical Trial page
- Check5 days agoChange DetectedThe history now shows 'Results Submitted' replacing 'No Results Posted'. The entry updates the record to indicate that study results have been submitted.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedSite revision updated to v3.5.0, replacing the prior v3.4.3.SummaryDifference0.1%

- Check26 days agoChange DetectedRevision label updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.1%

- Check55 days agoChange DetectedA new revision entry (v3.4.2) was added to the history, and earlier items including a government funding notice and revision v3.4.1 were removed.SummaryDifference0.6%

- Check62 days agoChange DetectedAdded a government funding/operating status notice and updated the revision metadata from v3.4.0 to v3.4.1.SummaryDifference0.6%

- Check69 days agoChange DetectedUI updates include a glossary toggle, color-coded change highlights (green for additions, red for deletions), and a 'Revision: v3.4.0' label on the history page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

Stay in the know with updates to Ociperlimab and Tislelizumab vs Pembrolizumab in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ociperlimab and Tislelizumab vs Pembrolizumab in Lung Cancer Clinical Trial page.